معرفی
Chris Packard is an Honorary Senior Research Fellow at the University of Glasgow's School of Cardiovascular & Metabolic Health. His research focuses on lipid metabolism, atherosclerosis, and cardiovascular risk management, with particular expertise in lipoprotein biology and dyslipidaemias. He has contributed to landmark studies like PROSPER and WOSCOPS evaluating statin therapies and cardiovascular outcomes.
His work addresses residual cardiovascular risk beyond traditional lipid markers, emphasizing novel targets like lipoprotein(a) and PCSK9 inhibition. Key contributions include advancing understanding of postprandial lipemia, triglyceride metabolism in diabetes, and genetic influences on atherosclerosis progression. He collaborates internationally on consensus statements and guidelines for lipid management strategies.
Publications highlight his role in developing predictive cardiovascular risk models and evaluating therapies targeting lipoprotein remnants and LDL cholesterol. His research bridges basic lipid biology with clinical applications, influencing both academic and clinical practice in cardiovascular prevention.
